Navigation Links
Protease inhibitors reach beyond HIV

The immunodeficiency that arises in HIV may be due to excessive programmed cell death of immune CD4 T cells. HIV protease inhibitors (PI) can block programmed cell death in virus-infected T cells in vitro, but have also been shown to induce programmed cell death at higher concentrations. The mechanisms for these paradoxical data are unclear, as is whether PI therapy would aid CD4 T cell reconstitution in HIV patients in vivo.

In a study appearing online on June 2 in advance of the print publication of the July 1 print issue of the Journal of Clinical Investigation, Andrew Badley and colleagues from Mayo Clinic examine whether PIs can inhibit programmed cell death in vivo and the mechanisms involved. The authors show that HIV PIs block programmed cell death induced by three relevant, virus-independent mouse models ?mice with experimental hepatitis, Staphylococcal-induced shock, and experimental stroke.

In each model, HIV PIs block programmed cell death and improve histology, survival, and function. The PIs prevent programmed cell death by maintaining mitochondrial integrity. These data show that PIs block programmed cell death in vivo and that related compounds may be useful for non-HIV disorders also characterized by excessive programmed cell death.


'"/>

Source:JCI


Page: 1

Related biology news :

1. HIV Patients May Be at Risk of Heart Problems When Taking Protease Inhibitor Drugs
2. Anthrax inhibitors identified by Burnham team
3. Enzyme inhibitors block replication of SARS virus
4. Sweet water taste paradoxically predicts sweet taste inhibitors
5. COX-2 inhibitors significantly reduce risk of cancer
6. Public collections of DNA and RNA sequence reach 100 gigabases
7. Natural vitamin E tocotrienol reaches blood at protective levels
8. NC State researchers redesign life for Mars and beyond
9. New classification of eukaryotes has implications for AIDS treatment, agriculture and beyond
10. Avian influenza virus in mammals spreads beyond the site of infection to other organ systems
11. Therapeutic prospects beyond Vioxx
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... YORK , April 5, 2017 Today ... is announcing that the server component of the HYPR ... known for providing the end-to-end security architecture that empowers ... HYPR has already secured over 15 million ... makers including manufacturers of connected home product suites and ...
(Date:4/4/2017)... April 4, 2017   EyeLock LLC , a ... the United States Patent and Trademark Office (USPTO) has ... the linking of an iris image with a face ... represents the company,s 45 th issued patent. ... very timely given the multi-modal biometric capabilities that have ...
(Date:3/30/2017)... ANGELES , March 30, 2017  On April ... Hack the Genome hackathon at Microsoft,s ... exciting two-day competition will focus on developing health and ... Hack the Genome is the ... been tremendous. The world,s largest companies in the genomics, ...
Breaking Biology News(10 mins):
(Date:6/16/2017)... , ... June 16, 2017 , ... CTNext , ... Innovation Awards (EIA), held at The LOFT at Chelsea Piers in Stamford. , Nine ... to a panel of judges for an opportunity to secure $10,000 awards to help ...
(Date:6/15/2017)... New Haven, CT (PRWEB) , ... June 15, ... ... announced today that it has secured a Series B round of financing in ... Innovations, and a group of private investors participated in the round. , The ...
(Date:6/15/2017)... ... June 15, 2017 , ... angelMD announced the closure ... Dan Parsley, angelMD’s SVP of Corporate Development, served as the syndicate leader for ... part of Saranas’ recently announced $4 million Series B financing round. , Saranas ...
(Date:6/15/2017)... ... June 15, 2017 , ... Adam Equipment, ... how to assemble a lab workstation. The guide outlines the procedure in four ... or Eclipse balance, AVT anti-vibration table, OIML/ASTM certified weights, and Adam DU specialized ...
Breaking Biology Technology: